Search Results 961-970 of 17147 for treatment resistant depression
Diagnosis & treatmentCare at Mayo Clinic. Oct. 14, 2023. Print. Living ... drug-resistant epilepsy April 07, 2025, 02:16 p.m. CDT; (VIDEO) When seizures ...
... treatment-refractory acute myeloid leukemia (AML). This study will also determine the pharmacokinetic (PK) parameters of ASP2215. Participation eligibility.
... drug-resistant focal epilepsy. In this paper, we describe a next-generation epilepsy management system that integrates local handheld and cloud-computing ...
... depression/expert-answers/clinical-depression/faq-20057770</loc><lastmod>2024-11-04T20:14:38-06:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href ...
Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL · Overview · Participation eligibility · Participating ...
Clinical Trials · A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) · More about research at ...
A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma · Overview.
But treatment can help you get the sleep you need. ... Stress, depression, anxiety and other mental health conditions may affect sleep. ... The hypoglossal nerve ...
... drug-resistant epilepsy April 07, 2025, 02:16 p.m. CDT; (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy April 02, 2025, 06:30 p.m. ...
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.